ROP Q1 2026 Earnings EPS Surpasses Estimates with 258 Beat Stock Edges Higher CRS Q1 2026 Earnings EPS Exceeds Expectations Amid Cautious Market Response Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline ICL Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Lower LSAK Q1 2026 Earnings Massive EPS Beat Signals Strong Profitability Surge